We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
-1.18%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$391M
AUM Growth
-$30.5M
Cap. Flow
-$19.7M
Cap. Flow %
-5.03%
Top 10 Hldgs %
48.1%
Holding
93
New
5
Increased
41
Reduced
33
Closed
7

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$7.56M
2
EXAS
Exact Sciences
EXAS
+$5.76M
3
UAA icon
Under Armour
UAA
+$5.07M
4
DORM icon
Dorman Products
DORM
+$2.13M
5
ISRG icon
Intuitive Surgical
ISRG
+$1.55M

Sector Composition

Rank Sector Weight
1 Healthcare 34.12%
2 Technology 18.35%
3 Financials 13.13%
4 Consumer Discretionary 7.6%
5 Communication Services 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
1
Intuitive Surgical
ISRG
$121B
$35.2M 8.99%
195,540
-8,946
-4% -$1.55M
MA icon
2
Mastercard
MA
$477B
$31.2M 7.98%
115,005
-27,428
-19% -$7.56M
AAPL icon
3
Apple
AAPL
$4.89T
$27M 6.9%
482,460
-9,512
-2% -$497K
ILMN icon
4
Illumina
ILMN
$29.4B
$16.7M 4.28%
56,574
-2,886
-5% -$851K
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$3.91T
$15.9M 4.08%
261,180
-7,500
-3% -$444K
IDXX icon
6
Idexx Laboratories
IDXX
$42.9B
$15.7M 4%
57,553
-68
-0.1% -$18.9K
EXAS
7
DELISTED
Exact Sciences
EXAS
$13.9M 3.54%
153,290
-50,530
-25% -$5.76M
ABMD
8
DELISTED
Abiomed Inc
ABMD
$11.2M 2.86%
62,835
+296
+0.5% +$64K
XYZ
9
Block Inc
XYZ
$45.9B
$11M 2.81%
177,485
-6,920
-4% -$470K
JPM icon
10
JPMorgan Chase
JPM
$939B
$10.4M 2.65%
88,243
-830
-0.9% -$93.9K
VFC icon
11
VF Corp
VFC
$6.68B
$8.87M 2.27%
99,665
+80
+0.1% +$6.83K
ADBE icon
12
Adobe
ADBE
$89.5B
$8.86M 2.26%
32,060
+775
+2% +$226K
VRTX icon
13
Vertex Pharmaceuticals
VRTX
$121B
$8.75M 2.24%
51,630
-4,220
-8% -$747K
PG icon
14
Procter & Gamble
PG
$343B
$8.05M 2.06%
64,720
-495
-0.8% -$58.5K
MSFT icon
15
Microsoft
MSFT
$2.84T
$7.41M 1.89%
53,128
-175
-0.3% -$24.1K
LMT icon
16
Lockheed Martin
LMT
$134B
$7.09M 1.81%
18,087
-137
-0.8% -$51.5K
LOW icon
17
Lowe's Companies
LOW
$116B
$6.49M 1.66%
58,995
-200
-0.3% -$21.1K
MCD icon
18
McDonald's
MCD
$188B
$6.43M 1.64%
29,767
-54
-0.2% -$11.6K
RETA
19
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$5.91M 1.51%
73,555
+465
+0.6% +$39.5K
BA icon
20
Boeing
BA
$165B
$5.9M 1.51%
15,427
+2,790
+22% +$997K
INTC icon
21
Intel
INTC
$466B
$5.62M 1.44%
108,369
+165
+0.2% +$8.11K
SO icon
22
Southern Company
SO
$110B
$5.61M 1.43%
89,951
+13
+0% +$754
VZ icon
23
Verizon
VZ
$194B
$5.55M 1.42%
92,029
+108
+0.1% +$6.22K
CVX icon
24
Chevron
CVX
$388B
$5.54M 1.42%
46,278
+85
+0.2% +$10.3K
CHD icon
25
Church & Dwight Co
CHD
$23.1B
$5.37M 1.37%
71,150
+65
+0.1% +$4.92K

Similar funds

Biondo Investment Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, Biondo Investment Advisors held 93 positions worth $391M, down 7.2% from $422M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Biondo Investment Advisors withdrew a net $19.7M in Q3 2019, closing 7 positions and reducing 33 holdings. Its most notable exit was Under Armour, an estimated $5.07M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 37% a quarter earlier, followed by Technology and Financials.

Against the trend, Biondo Investment Advisors opened a new position in Iovance Biotherapeutics worth $3.36M.

  • Biondo Investment Advisors's largest Q3 2019 buy was Iovance Biotherapeutics: 184,835 shares worth $3.36M.
  • Biondo Investment Advisors added most to Boeing in Q3 2019, an estimated $997K increase.
  • Biondo Investment Advisors's biggest Q3 2019 reduction was Mastercard, cutting an estimated $7.56M.
  • Biondo Investment Advisors fully exited Under Armour in Q3 2019, selling an estimated $5.07M.
  • Biondo Investment Advisors's ten largest holdings make up 48% of its $391M portfolio in Q3 2019.
  • Biondo Investment Advisors opened 5 new positions and closed 7 in Q3 2019.
  • Biondo Investment Advisors's portfolio value fell 7.2% quarter-over-quarter to $391M.

Based on Biondo Investment Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.